Fibrinorel 1gm Injection

About

Fibrogen-I Injection and Fibrinorel 1gm Injection deliver human fibrinogen concentrate, a critical plasma glycoprotein that stands at the nexus of the coagulation pathway. Fibrinogen is the precursor to fibrin, which, upon cleavage by thrombin, polymerizes to form the stable fibrin meshwork that constitutes the structural basis of a blood clot. This robust clot is absolutely essential for achieving effective hemostasis and facilitating proper wound healing. These therapeutic agents are specifically employed to manage and control bleeding episodes in patients diagnosed with either congenital or acquired fibrinogen deficiencies, conditions where the body's inherent capacity to form adequate clots is severely compromised. By supplementing deficient fibrinogen levels, these injections effectively restore the crucial components necessary for robust clot formation, thereby preventing and treating significant hemorrhage.

Uses

• Treatment of congenital afibrinogenemia.
• Management of acquired fibrinogen deficiency.
• Control of bleeding in surgical procedures.
• Support for massive hemorrhage with dilutional coagulopathy.

Directions For Use

Administer intravenously after reconstitution, as directed by a healthcare professional. Dosage depends on the patient's fibrinogen levels and clinical condition.

Benefits

• Restores fibrinogen levels rapidly.
• Promotes effective clot formation.
• Controls active bleeding episodes.
• Reduces blood loss during surgery.
• Essential for patients with inherited deficiencies.
• Improves hemostasis in critical situations.

Side Effects

• Thromboembolic events (e.g., DVT, PE)
• Allergic reactions (rash, itching, hives)
• Fever
• Chills
• Nausea
• Headache
• Tachycardia
• Hypotension
• Injection site reactions
• Viral transmission (theoretical, despite viral inactivation)
• Antibody formation against fibrinogen
• Dyspnea

Safety Measures

• Alcohol - No direct interaction with alcohol. However, alcohol can affect liver function, which is involved in clotting factor synthesis.
• Pregnancy - Use only if clearly needed. Limited data available, but benefits may outweigh risks in severe bleeding.
• Breastfeeding - It is unknown if fibrinogen is excreted in human milk. Consult a doctor to weigh risks and benefits.
• Liver - Use with caution in severe liver disease, as it may exacerbate coagulopathy or affect fibrinogen metabolism.
• Kidney - No specific dose adjustment needed for renal impairment, but monitor fluid balance carefully.
• Lung - Use with caution in patients with a history of pulmonary embolism or other thrombotic events due to increased risk.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.